Tempus AI, Inc. is trading at $48.80 (down 6.6%) as the stock retreats from a sharp multi-day run-up amid a broader tech-led market selloff.
- The stock is likely seeing profit-taking after yesterday’s double-digit gain, which followed the announcement of a new open-source digital pathology consortium with Yale New Haven Hospital and Memorial Sloan Kettering.
- Shares are also being pressured by a wider risk-off move in the technology sector, with the Nasdaq Composite currently down 1.86%.
- There are no fresh company-specific headlines this morning to account for the move.